Sartorius (OTCMKTS:SARTF) Short Interest Up 407.8% in April

Sartorius (OTCMKTS:SARTFGet Free Report) was the target of a large growth in short interest in the month of April. As of April 30th, there was short interest totaling 2,331 shares, a growth of 407.8% from the April 15th total of 459 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days. Currently, 0.0% of the company’s shares are sold short.

Sartorius Price Performance

OTCMKTS SARTF opened at $212.35 on Wednesday. The company has a current ratio of 0.95, a quick ratio of 0.49 and a debt-to-equity ratio of 0.89. Sartorius has a 1 year low of $181.58 and a 1 year high of $226.33. The company has a market cap of $7.27 billion, a PE ratio of 98.77 and a beta of 0.98. The stock’s 50-day moving average price is $224.37 and its two-hundred day moving average price is $220.74.

Sartorius Company Profile

(Get Free Report)

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.

Featured Articles

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.